Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NDNF antisense RNA 1 (NDNF-AS1)
- Target
- NDNF-AS1
- Molecular classification
- Long non-coding RNA (lncRNA), Natural antisense transcript (NAT), Non-coding RNA
01
Overview
NDNF antisense RNA 1 (NDNF-AS1) is a long non-coding RNA gene transcribed from the antisense strand of the NDNF locus. It belongs to the class of natural antisense transcripts (NATs) and is affiliated with lncRNAs, which are defined as transcripts longer than 200 nucleotides that regulate gene expression by various mechanisms, such as altering mRNA stability, splicing, or translation. The precise biological roles and mechanisms of NDNF-AS1 remain unclear, and there is currently no evidence demonstrating its involvement as a therapeutic target, validated biomarker, or disease-associated molecule. Its molecular identity is well-established, and there are no major aliases outside its canonical gene name and abbreviation. NDNF-AS1 is listed in major genetic databases and conforms to current standards in lncRNA classification.
- Other names
- NDNF-AS1NDNF antisense RNA 1GC04P121074GC04P121127GC04P121247GC04P121414GC04P121625GC04P121847GC04P122073GC04P122288
02
Biological functions
Likely regulates gene expression of NDNF through antisense mechanisms, including influencing mRNA stability, splicing, and translationMay participate in epigenetic regulation and cis/trans modulation
03
Disease associations
No established association with specific diseases such as cancer, neurodegenerative disorders, or cardiovascular diseases
Beyond the preview
Go deeper on NDNF antisense RNA 1 (NDNF-AS1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NDNF antisense RNA 1 (NDNF-AS1).